Nonmelanoma Skin Cancer
Tips
High-Potency Topical Steroid Treatment of Multiple Keratoacanthomas Associated With Prurigo Nodularis
Patients who present with multiple keratoacanthomas (KAs) associated with prurigo nodularis often pose a treatment challenge. We have found...
Article
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Case Letter
Squamous Cell Carcinoma in Hidradenitis Suppurativa Lesions Following Tumor Necrosis Factor α Inhibitors
Consider biopsy of representative lesions in men older than 20 years with moderate to severe disease of the groin and/or buttocks prior to...
Conference Coverage
Hedgehog inhibitor alternative dosing advantageous for BCC
The goal of step-down therapy is lifelong tolerability.
Clinical Review
Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systematic Review
Dermatologists may play a role in diagnosing breast cancer through cutaneous metastasis, even in patients without a history of breast cancer.
Cosmeceutical Critique
The cutaneous benefits of bee venom, Part II: Acupuncture, wound healing, and various potential indications
Bee venom has been shown to provide many salutary effects, but more research is needed, according to Dr. Baumann.
For Residents
The Genital Examination in Dermatologic Practice
The genital area is not routinely included in the total-body skin examination (TBSE) despite malignancies and inflammatory conditions involving...
From the Journals
Less pain, same gain with tirbanibulin for actinic keratosis
The results, assessed at day 57 and out to 1 year of follow-up, were associated with recurrence of lesions at 1 year.
Photo Challenge
Eruptive Annular Papules on the Trunk of an Organ Transplant Recipient
A 50-year-old Black woman with systemic lupus erythematosus and a renal transplant 15 years prior due to lupus nephritis presented with a...
Tips
Hidden Basal Cell Carcinoma in the Intergluteal Crease
Intergluteal crease BCC is a rare finding and often can be overlooked. When promptly identified, prognosis is good. Being educated on the...
News from the FDA/CDC
Cemiplimab approved for locally advanced, metastatic basal cell carcinoma
The approval is based on phase 2 trial results.